Alnylam Pharmaceuticals
Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.
About
Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company that develops innovative therapies based on RNA interference (RNAi). By silencing disease-causing genes at the genetic level, the company provides transformative treatments for patients with rare and common genetic, metabolic, and cardiovascular diseases. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Alnylam Pharmaceuticals do?
Alnylam Pharmaceuticals is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare. It is based in Cambridge, Massachusetts, United States and was founded in 2002. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Alnylam Pharmaceuticals headquartered?
Alnylam Pharmaceuticals is headquartered in Cambridge, Massachusetts, United States.
When was Alnylam Pharmaceuticals founded?
Alnylam Pharmaceuticals was founded in 2002.
What industry does Alnylam Pharmaceuticals operate in?
Alnylam Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.